Albert Cha's Net Worth

$54.2 Thousand

Estimate Recalculated Nov 7, 2024 04:51PM EST

Who is Albert Cha

Albert Cha does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BIOFORM MEDICAL INC, Biodel Inc, Biohaven Pharmaceutical Holding Co Ltd., Aclaris Therapeutics, Inc., KalVista Pharmaceuticals, Inc., ProNAi Therapeutics Inc, Menlo Therapeutics Inc., and Capnia, Inc..

SEC CIK

Albert Cha's CIK is 0001397906

Past Insider Trading and Trends

2023 was Albert Cha's most active year for acquiring shares with 3 total transactions. Albert Cha's most active month to acquire stocks was the month of August. 2023 was Albert Cha's most active year for disposing of shares, totalling 3 transactions. Albert Cha's most active month to dispose stocks was the month of August. 2023 saw Albert Cha paying a total of $134,820.00 for 28,000 shares, this is the most they've acquired in one year. In 2023 Albert Cha cashed out on 36,000 shares for a total of $189,050.40, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIOFORM MEDICAL INC

Investor
Updated Nov 14, 2007
Form 4
Nov 14, 2007
1.91M
Options
Nov 09
Form 3
Nov 06, 2007
56.00K
Showing 2 results

Biodel Inc

Investor
Updated Mar 04, 2008
Form 4
10.00K
Mar 04, 2008
10.00K
Grant
Feb 28
Form 4
-7.83%
-132.00K
$15.50
-$2.05M
Feb 14, 2008
1.55M
Sale
Feb 12
Form 4
May 18, 2007
1.73M
Options
May 16
Form 3
May 10, 2007
607.02K
Showing 4 results

Biohaven Pharmaceutical Holding Co Ltd.

Investor
Updated May 03, 2018
Form 4
18.00K
May 03, 2018
18.00K
Grant
May 01
Form 4
3.68%
72.73K
$27.50
$2.00M
Mar 15, 2018
2.05M
Grant
Mar 14
Form 4
31.19%
470.00K
$17.00
May 09, 2017
1.98M
Purchase
May 09
Form 3
May 03, 2017
Showing 4 results

Aclaris Therapeutics, Inc.

Investor
Updated Jul 01, 2016
Form 4
6.63K
Jul 01, 2016
6.63K
Grant
Jun 29
Form 4
-65.50%
-7.96M
$11.00
Oct 13, 2015
4.19M
Buy-Options
Oct 13
Form 4
4.61%
13.35K
$11.00
$146.87K
Oct 09, 2015
303.21K
Purchase
Oct 07
Form 3
Oct 06, 2015
289.85K
Showing 4 results

KalVista Pharmaceuticals, Inc.

Investor
Updated Sep 28, 2023
Form 4
10.00K
Sep 28, 2023
10.00K
Grant
Sep 26
Form 4
-100.00%
-18.00K
$9.00
-$54.23K
Sep 13, 2023
Sale
Sep 11
Form 4
10.00K
Oct 17, 2022
10.00K
Grant
Oct 13
Form 4
10.00K
Oct 01, 2021
10.00K
Grant
Sep 30
Form 4
11.31%
115.69K
$17.24
$1.99M
Nov 03, 2020
1.14M
Purchase
Oct 30
Form 4
7.00K
Oct 02, 2020
7.00K
Grant
Oct 01
Form 4
7.00K
Oct 03, 2019
7.00K
Grant
Oct 02
Form 4
5.17%
56.37K
$16.99
$957.74K
Jul 30, 2019
1.15M
Purchase
Jul 26 - Jul 29
Form 4
5.95%
61.28K
$17.74
$1.09M
Jul 19, 2019
1.42M
Purchase
Jul 17 - Jul 19
Form 4
7.00K
Oct 05, 2018
7.00K
Grant
Oct 03
Form 4
352.56%
1.06M
$17.00
$18.00M
Sep 12, 2018
1.36M
Purchase
Sep 10
Form 4
6.00K
Sep 29, 2017
6.00K
Grant
Sep 27
Form 4
12.00K
Mar 27, 2017
12.00K
Grant
Mar 23
Form 4/A
31.72%
1.01M
$5.00
Apr 27, 2015
4.20M
Purchase
Apr 14
Form 4
31.72%
1.01M
$5.00
Apr 14, 2015
4.20M
Purchase
Apr 14
Form 3
Apr 08, 2015
Showing 16 results

ProNAi Therapeutics Inc

Investor
Updated Jul 21, 2015
Form 4
2.50%
328.97K
$11.11
$4.31M
Jul 21, 2015
13.48M
Purchase
Jul 21
Form 3
Jul 15, 2015
Showing 2 results

Menlo Therapeutics Inc.

Investor
Updated Jan 24, 2018
Form 3
Jan 24, 2018
Showing 1 results

Capnia, Inc.

Investor
Updated Nov 20, 2014
Form 4
-131.30%
-6.13M
Nov 20, 2014
24.93M
Sale
Nov 18
Form 3
Nov 13, 2014
31.76K
Showing 2 results